State Board Of Administration Of Florida Retirement System Neurocrine Biosciences Inc Transaction History

State Board Of Administration Of Florida Retirement System

  • $51.7 Billion
  • Q4 2024

A detailed history of State Board Of Administration Of Florida Retirement System transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 97,443 shares of NBIX stock, worth $10.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
97,443
Previous 97,533 0.09%
Holding current value
$10.4 Million
Previous $11.2 Million 18.45%
% of portfolio
0.03%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$111.62 - $139.44 $10,045 - $12,549
-90 Reduced 0.09%
97,443 $13.3 Million
Q3 2024

Nov 08, 2024
SELL
$114.58 - $153.15 $664,564 - $888,270
-5,800 Reduced 5.61%
97,533 $11.2 Million
Q2 2024

Aug 08, 2024
SELL
$130.86 - $143.19 $799,947 - $875,320
-6,113 Reduced 5.59%
103,333 $14.2 Million
Q1 2024

May 08, 2024
BUY
$130.4 - $143.74 $280,751 - $309,472
2,153 Added 2.01%
109,446 $15.1 Million
Q4 2023

Feb 09, 2024
BUY
$106.07 - $132.76 $10,182 - $12,744
96 Added 0.09%
107,293 $14.1 Million
Q3 2023

Nov 08, 2023
BUY
$94.02 - $117.1 $14,103 - $17,565
150 Added 0.14%
107,197 $12.1 Million
Q2 2023

Aug 11, 2023
SELL
$89.53 - $104.87 $214,782 - $251,583
-2,399 Reduced 2.19%
107,047 $10.1 Million
Q4 2022

Feb 07, 2023
SELL
$106.72 - $127.06 $179,289 - $213,460
-1,680 Reduced 1.51%
109,446 $13.1 Million
Q3 2022

Nov 08, 2022
SELL
$92.03 - $107.81 $223,632 - $261,978
-2,430 Reduced 2.14%
111,126 $11.8 Million
Q2 2022

Aug 05, 2022
SELL
$75.79 - $100.07 $688,552 - $909,135
-9,085 Reduced 7.41%
113,556 $11.1 Million
Q1 2022

May 06, 2022
SELL
$72.45 - $94.81 $7,969 - $10,429
-110 Reduced 0.09%
122,641 $11.5 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $46,356 - $61,820
-582 Reduced 0.47%
122,751 $10.5 Million
Q3 2021

Nov 08, 2021
SELL
$86.18 - $99.03 $279,050 - $320,659
-3,238 Reduced 2.56%
123,333 $11.8 Million
Q2 2021

Aug 10, 2021
SELL
$89.43 - $102.27 $1.63 Million - $1.86 Million
-18,229 Reduced 12.59%
126,571 $12.3 Million
Q1 2021

May 10, 2021
SELL
$87.57 - $119.4 $327,511 - $446,556
-3,740 Reduced 2.52%
144,800 $14.1 Million
Q4 2020

Feb 08, 2021
BUY
$86.91 - $108.33 $982,083 - $1.22 Million
11,300 Added 8.23%
148,540 $14.2 Million
Q3 2020

Nov 09, 2020
BUY
$96.16 - $135.15 $150,009 - $210,834
1,560 Added 1.15%
137,240 $13.2 Million
Q2 2020

Aug 07, 2020
BUY
$85.09 - $130.36 $1.17 Million - $1.79 Million
13,751 Added 11.28%
135,680 $16.6 Million
Q1 2020

May 05, 2020
BUY
$75.11 - $113.76 $45,516 - $68,938
606 Added 0.5%
121,929 $10.6 Million
Q4 2019

Feb 03, 2020
BUY
$86.8 - $118.57 $147,126 - $200,976
1,695 Added 1.42%
121,323 $13 Million
Q3 2019

Nov 07, 2019
SELL
$83.82 - $101.5 $15,003 - $18,168
-179 Reduced 0.15%
119,628 $10.8 Million
Q2 2019

Aug 05, 2019
BUY
$72.24 - $91.27 $294,233 - $371,742
4,073 Added 3.52%
119,807 $10.1 Million
Q1 2019

May 03, 2019
SELL
$69.31 - $91.53 $117,133 - $154,685
-1,690 Reduced 1.44%
115,734 $10.2 Million
Q4 2018

Feb 01, 2019
BUY
$68.32 - $124.36 $58,755 - $106,949
860 Added 0.74%
117,424 $8.39 Million
Q3 2018

Oct 31, 2018
SELL
$98.88 - $125.85 $405,605 - $516,236
-4,102 Reduced 3.4%
116,564 $14.3 Million
Q2 2018

Aug 06, 2018
BUY
$75.3 - $105.99 $132,528 - $186,542
1,760 Added 1.48%
120,666 $11.9 Million
Q1 2018

May 04, 2018
BUY
$75.88 - $92.43 $216,182 - $263,333
2,849 Added 2.45%
118,906 $9.86 Million
Q4 2017

Feb 01, 2018
SELL
$58.53 - $77.59 $255,717 - $338,990
-4,369 Reduced 3.63%
116,057 $9.01 Million
Q3 2017

Oct 31, 2017
BUY
$47.97 - $61.28 $5.78 Million - $7.38 Million
120,426
120,426 $7.38 Million

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.3B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email